FDA authorizes emergency use for quicker, but less reliable coronavirus antigen test

Coronavirus testing.
(Image credit: ANGELA WEISS/AFP via Getty Images)

With the United States struggling to meet the recommended quota of coronavirus tests per day, the Food and Drug Administration issued the first emergency use authorization Friday for a COVID-19 antigen test.

The test, produced by San Diego-based manufacturer Quidel, can diagnose COVID-19 by detecting fragments of protein found on or within the virus present in samples collected from the nasal cavity using swabs. The test produces results within minutes — much more quickly than many other tests on the market, which are more complex to conduct and analyze — but the technology is also more liable to result in false negatives, so an additional PCR test may be necessary to confirm.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us
Tim O'Donnell

Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.